KURA
KURA
US50127T1097
Kura Oncology, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
942.98M EUR
975.83M EUR
721.64M EUR
912.81M EUR
Enterprise Value
441.3M EUR
930.04M EUR
706.83M EUR
784.17M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-4.51x
--
--
--
Price to Sales
12.21x
12.64x
10.07x
17.1x
Price to Book
19.49x
20.15x
6.69x
5.24x
EV/Revenue
5.71x
12.04x
9.87x
14.69x
EV/EBITDA
-1.39x
--
--
--
Price to FCF (P/FCF)
--
--
--
599.35x
EV/FCF
--
--
--
514.89x
FCF Yield
-17.59%
-12.03%
-11.7%
0.17%
ende